What is dendritic vaccine?

Dendritic vaccine is a vaccine for the treatment of cancer, including the use of its own dendritic cells of the body, specialized immune cells responsible for presenting T-cells of body for destruction. For vaccine production, dendritic cells are harvested from the patient, exposed to tumor cells in culture and then reappear. Sensitized cells are locked on tumor cells in the body to target them by the immune system. The term "vaccine" is somewhat misleading here because dendritic vaccine does not prevent cancer; It helps to treat him. Rather than being used as the first line of treatment in patients, it was available through clinical trials in patients who did not respond to conventional treatment. Clinical studies are used to collect important data for the development of new medical treatments, from the development of suitable therapeutic techniques of dose refining.

Dendritic cells naturally occur in low concentrations throughout the body. How their name, derived from the word for the "tree", napoShe sees, have a branched look. They are part of the immune system and work by locked on antigens and present them to killer cells such as T-cells and NK cells, allowing the immune system to eliminate foreign proteins from the body. Dendritic vaccine uses this feature and uses it to work more efficiently and faster.

This is an example of cell -based immunotherapy where the patient's own body is used to develop the treatment of the disease. The side effects of such treatment are radically reduced because they use natural processes rather than introduce chemical compounds into the body and treatment can be adapted to the patient's specifics to target cancer. Such treatments are expensive to be expensive because they require considerable work and preparation, and may not be accessible to all patients.

If the treatment of dendritic vaccine options for patient with cancer, the oncologist will discuss it and provide more infoRemovion on how and where access to treatment. The rate of success in various cancer is quite variable and may also differ between studies. Clinical evaluation participants should also be aware of the increased risks associated with participating in medical research. Scientists will provide detailed information about the nature of the research and how the information will be used, and patients are recommended to ask if they are uncertain or unclear at any concepts.